Nasal spray - metered deviceIntranasal5 mg
Sermorelin is based on part of the body's natural signal for growth hormone release. It has a longer history of human medical research than many peptides in this category. This nasal presentation still needs to be assessed on its own evidence, rather than borrowing conclusions from injectable products.
Shipping Information
Shipping Information
Free Shipping
Decor Outdoor offers free regular shipping on all orders shipped to residential or commercial addresses within the contiguous United States. Orders are delivered Monday through Friday (excluding holidays).Drop Shipping
We are an online-only luxury furniture and lighting boutique, and do not have a warehouse. Consequently, all orders are drop shipped directly from our manufacturers to your door. If your order includes items from more than one manufacturer, you will receive multiple deliveries. Because we are dependent on the on-hand inventory of our manufacturing partners, some items listed on our site may not actually be available right away. Please call us at 888.784.4644 or via our contact form with any stocking questions and we'll get in touch with the appropriate manufacturer for answers, before you place your order.Ground Shipping
Small parcel items ship regular ground via delivery services such as FedEx, UPS or DHL. Orders typically take 2-3 business days to process and in-stock items will usually be delivered 3-5 days from the date that they ship (depending on origin and destination). If there is a delay, you will be notified by email. No signature is required for standard ground shipping, so you may want to make arrangements to have packages brought inside soon after delivery, if you are unable to receive it in person.
Storage & Handling
Follow the storage instructions on your product label and the information supplied with your batch. Storage and handling requirements vary by product and presentation.
Sermorelin is a short, active part of growth hormone releasing hormone. It has a history in medical development, but format and route are important when comparing any current preparation with those studies.
Growth hormone signalling research and specialist assessment of the supplied presentation.
The PHI Perspective
A longer research history is useful only when the evidence fits the product being discussed.
For clinician-directed use only where permitted.
How It Works
It mimics the natural signal that prompts growth hormone release. Absorption through a nasal formulation cannot be assumed to match injection.
What the Research SuggestsEarlier clinical evidence concerns defined products and uses. A nasal presentation needs its own evidence for absorption, dose delivery and effect.
Evidence level: A (former licensed paediatric indication) and C (off-label adult use, no controlled trials)
Storage & Handling
Store lyophilised vial at 2-8 C, protected from light.
Active compound: Sermorelin (GHRH 1-29)
Mechanism of ActionBinds the GHRH receptor on anterior pituitary somatotrophs, stimulating synthesis and pulsatile release of growth hormone, with consequent hepatic IGF-1 production. Because the pituitary remains the effector, physiological negative feedback via somatostatin and IGF-1 is preserved, which limits supraphysiological elevation.
Clinical Evidence BaseFormal clinical development and prior FDA approval for paediatric growth hormone deficiency, providing established human safety and pharmacodynamic data. Adult use for body composition, sleep or ageing endpoints has not been established in controlled trials and is off-label.
Safety & PrecautionsWell characterised from its licensed period. The most common effect is injection-site reaction; flushing, headache, dizziness and transient taste disturbance have been reported. Because it works through the pituitary with intact feedback, the risk of supraphysiological growth hormone exposure is lower than with exogenous GH, but not absent. Contraindicated where malignancy is present or suspected. Concurrent glucocorticoid therapy, hypothyroidism and obesity all blunt the response. IGF-1 monitoring is advised.
ContraindicationsActive or suspected malignancy; pregnancy and breastfeeding; untreated hypothyroidism (blunts response); acute critical illness; known hypersensitivity.
Literature & ReferencesPrakash A, Goa KL. BioDrugs, 1999 - sermorelin, a review of its use in growth hormone deficiency. | Walker RF. Clin Interv Aging, 2006 - sermorelin, a better approach to management of adult-onset GH insufficiency. | Corpas E et al. J Clin Endocrinol Metab, 1992 - GHRH 1-29 twice daily reverses the decreased GH and IGF-1 of old men.
